Trial
NCT04071756
Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Bayer
Condition
Solid Tumor
Intervention
Topical Tazarotene
Why stopped
Difficulty with patient recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-07